Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Rivia logo — Know better. Act better.

Rivia

Know better. Act better.

Founded 2022 Switzerland Zurich, Switzerland 34 employees Series A Total: $16.00M

General Information

Company Name Rivia
Founded Year 2022
Location Switzerland Zurich, Switzerland
Employees 34
Funding Stage Series A
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Rivia. To contact Rivia, visit rivia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Rivia compare?

A PDF of Rivia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Rivia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Rivia

Rivia, founded in 2022 and headquartered in Switzerland, is a promising startup operating in the clinical trial intelligence sector. With its mission embodied in the slogan "Know better. Act better.", the Zurich-based company offers a sophisticated data engine aimed at innovating the approach to bringing new drugs to market.

In just two years, Rivia has made significant strides, with numerous European and US biotech firms utilizing its platform to enhance clinical trials. These collaborations have resulted in earlier understanding of therapeutic potentials and improved trial efficiency. As Rivia looks forward, it plans to scale its platform further to expedite the delivery of groundbreaking therapies to market.

To support its growth, Rivia secured a €13.00M Series A investment on 01 March 2026 from investors including Speedinvest, Earlybird, Nina Ventures, Amino Collective, and Defiant, highlighting investor confidence in its potential to transform the clinical trial landscape.

Business keywords: clinical trial intelligence, data engine, clinical trial execution, therapeutic potential analysis, drug discovery, clinical operations, medical monitoring, biotech innovation, therapeutic innovators, clinical development, platform scaling, embedded intelligence, trial outcomes improvement, next-gen operating system

Services & Products

Rivia Core - Intelligence Layer
Rivia Detect - Data Quality Management
Rivia Spark - Visual Intelligence

Target Customers

Biopharma Companies Clinical Teams Executives in Healthcare Medical and Clinical Scientists Clinical Operations Personnel

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €13.00M 5
Speedinvest Earlybird Nina Ventures
Speedinvest, Earlybird +3
01 Mar 2026
Seed €3.00M 3
Speedinvest Nina Ventures Amino Collective
Speedinvest, Nina Ventures +1
01 Jun 2024

Latest News

View All
UK startup Pharosyn raises €2.5 million for pharma competitive intelligence platform — Eu-startups
UK startup Pharosyn raises €2.5 million for pharma competitive intelligence platform
Eu-startups Sep 02, 2026
Swiss BioTech startup ALP Bio raises €1.9 million to advance immune organoid and AI platform — Eu-startups
Swiss BioTech startup ALP Bio raises €1.9 million to advance immune organoid and AI platform
Eu-startups Apr 30, 2026
Earlybird closes €360M Fund VIII, its largest ever, with a new perpetual ownership model and a deept... — Thenextweb
Earlybird closes €360M Fund VIII, its largest ever, with a new perpetual ownership model and a deeptech-first thesis
Thenextweb Apr 30, 2026
Earlybird closes €360M Fund VIII, doubling down on deeptech and long-term ownership — Tech
Earlybird closes €360M Fund VIII, doubling down on deeptech and long-term ownership
Tech Apr 30, 2026
Recap: Europe’s top funding rounds this week (16 -22 March) — Thenextweb
Recap: Europe’s top funding rounds this week (16 -22 March)
Thenextweb Mar 22, 2026
Rivia raises $15M to fix the broken data infrastructure behind clinical trials — Tech
Rivia raises $15M to fix the broken data infrastructure behind clinical trials
Tech Mar 18, 2026

Rivia Alternatives & Competitors

View All Alternatives
Rivia vs
Lanthio Pharma
Lanthio Pharma The Netherlands

Biopharmaceutical company discovering and developing stabilized lanthipeptides in oncology and criti...

Debt Financing
1 employees
Biotechnology, Health and Wellness
Rivia vs
Arno Therapeutics Inc (ARNI)
Arno Therapeutics Inc (ARNI)

Arno Therapeutics Inc (ARNI) is a pharmaceuticals company based out of Parsippany, NJ, United States...

Post-IPO Equity
3 employees
Biopharma, Biotechnology
Rivia vs
NGM Biopharmaceuticals
NGM Biopharmaceuticals United States

Explorers on the frontier of life-changing science.

Growth
83 employees
View all alternatives

FAQ About Rivia

Know better. Act better.
Rivia was founded in 2022.
Rivia is headquartered in Zurich, Switzerland.
Rivia has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Rivia has approximately 34 employees.
Rivia has completed 2 funding rounds, raising a total of $16.00M. The latest funding stage is Series A.
Rivia offers: Rivia Core - Intelligence Layer, Rivia Detect - Data Quality Management, Rivia Spark - Visual Intelligence.
Top alternatives and competitors to Rivia include Lanthio Pharma, Arno Therapeutics Inc (ARNI), NGM Biopharmaceuticals, Precision For Medicine, KeifeRx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rivia and Lanthio Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Rivia, https://bouncewatch.com/company/rivia, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout